Plasma-derived cfDNA to reveal potential biomarkers of response prediction and monitoring in non-small cell lung cancer (NSCLC) patients on immunotherapy.

被引：0
|
作者：
Vallnia, Francesco
Assayag, Karen
Ulz, Peter
Drake, Adam
Warsinske, Hayley
St John, John
Putcha, Girish
Cabel, Luc
Beaucaire-Danel, Sophie
Girard, Nicolas
Bidard, francois-Clement
机构：
[1] Freenome, San Francisco, CA USA
[2] Inst Curie, Paris, France
[3] Inst Curie, Dept Oncol, Paris, France
[4] Inst Curie, Inst Thorax Curie Montsouris, Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9588
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Radiomic biomarkers for the prediction of immunotherapy outcome in patients with metastatic non-small cell lung cancer.
    Trebeschi, Stefano
    Kurilova, Ieva
    Calin, Adriana M.
    Lambregts, Doenja M. J.
    Smit, Egbert F.
    Aerts, Hugo
    Beets-Tan, Regina G. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [22] Analysis of non-small cell lung cancer (NSCLC) circulating biomarkers for monitoring early response to radiation therapy
    Purcell, Emma
    Niu, Zeqi
    Grzesik, Madeline
    Owen, Sarah
    Fairbairn, Heather
    Jolly, Shruti
    Nagrath, Sunitha
    CLINICAL CANCER RESEARCH, 2020, 26 (11) : 87 - 87
  • [23] Biomarkers for immunotherapy resistance in non-small cell lung cancer
    Rother, Catriona
    John, Tom
    Wong, Annie
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [24] Metabolic Parameters as Biomarkers of Response to Immunotherapy and Prognosis in Non-Small Cell Lung Cancer (NSCLC): A Real World Experience
    Monaco, Lavinia
    Gemelli, Maria
    Gotuzzo, Irene
    Bauckneht, Matteo
    Crivellaro, Cinzia
    Genova, Carlo
    Cortinovis, Diego
    Zullo, Lodovica
    Ammoni, Luca Carlofrancesco
    Bernasconi, Davide Paolo
    Rossi, Giovanni
    Morbelli, Silvia
    Guerra, Luca
    CANCERS, 2021, 13 (07)
  • [25] Association of azole antifungals with survival in patients with non-small cell lung cancer receiving immunotherapy.
    Sebastian, Nikhil
    Stokes, William A.
    Behera, Madhusmita
    Jiang, Renjian
    Gutman, David
    Giuste, Felipe
    Burns, Abigail
    Ramalingam, Selvi
    Sukhatme, Vidula
    Lowe, Michael C.
    Ramalingam, Suresh S.
    Sukhatme, Vikas
    Moghanaki, Drew
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [26] The Combination of Radiotherapy With Immunotherapy and Potential Predictive Biomarkers for Treatment of Non-Small Cell Lung Cancer Patients
    Meng, Lu
    Xu, Jianfang
    Ye, Ying
    Wang, Yingying
    Luo, Shilan
    Gong, Xiaomei
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [27] Progress on neoadjuvant immunotherapy in resectable non-small cell lung cancer and potential biomarkers
    Wu, Xinyu
    Chau, Yi Fung
    Bai, Hua
    Zhuang, Xiaofei
    Wang, Jie
    Duan, Jianchun
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [28] KRAS mutations in the circulating free DNA (cfDNA) of non-small cell lung cancer (NSCLC) patients
    Garzon, Monica
    Villatoro, Sergi
    Teixido, Cristina
    Mayo, Clara
    Martinez, Alejandro
    Llanos Gil, Maria de Los
    Viteri, Santiago
    Morales-Espinosa, Daniela
    Rosell, Rafael
    TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (05) : 511 - 516
  • [29] Immunotherapy in previously treated non-small cell lung cancer (NSCLC)
    Leal, Ticiana A.
    Ramalingam, Suresh S.
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S422 - S432
  • [30] Clinical implication of monitoring PD-L1+circulating tumor cells (CTCs) in patients with non-small cell lung cancer (NSCLC) receiving immunotherapy.
    Hoffmann, Andrew Daniel
    Davis, Andrew A.
    Iams, Wade Thomas
    Oh, Michael S.
    Lentz, Robert William
    Chae, Young Kwang
    Liu, Huiping
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345